Screening of and mechanism underlying the action of serum- and glucocorticoid-regulated kinase 3-targeted drugs against estrogen receptor-positive breast cancer
Duanfang Zhou(Chongqing Medical University), Weiying Zhou(Chongqing Medical University), Xiaoping Yu(Chongqing Medical University), Hongfang Zeng(Chongqing University), Xu Liu(Chongqing Medical and Pharmaceutical College), Huan Zhang(Huazhong University of Science and Technology), Xiaoli Li(Fujian Medical University), Bo Chen(Unknown), Yalan Wang(Yanbian University), Hongyao Li(Sichuan University), Yi Song(Army Medical University), Qichen He(Chongqing Medical and Pharmaceutical College)
Cited by 6
Related Papers
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
The Physiologic Role of CD19 Cytoplasmic Tyrosines
|Immunity|2002|145
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
|Current Pharmaceutical Design|2017|132
Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway
|Journal of Cellular Physiology|2019|115